| Primary |
| Drug Use For Unknown Indication |
36.2% |
| Product Used For Unknown Indication |
12.7% |
| Immunodeficiency Common Variable |
10.8% |
| Primary Immunodeficiency Syndrome |
7.8% |
| Off Label Use |
7.0% |
| Premedication |
6.2% |
| Hypogammaglobulinaemia |
2.1% |
| Stevens-johnson Syndrome |
1.9% |
| Toxic Epidermal Necrolysis |
1.9% |
| Selective Iga Immunodeficiency |
1.7% |
| Immunodeficiency |
1.6% |
| Demyelinating Polyneuropathy |
1.4% |
| Polymyositis |
1.3% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.2% |
| Hypertension |
1.2% |
| Pain |
1.1% |
| Asthma |
1.0% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Multifocal Motor Neuropathy |
1.0% |
| Intentional Drug Misuse |
0.9% |
|
| Infection |
13.6% |
| Death |
12.1% |
| Hepatitis C |
11.4% |
| Vomiting |
9.5% |
| Pyrexia |
8.4% |
| Tachycardia |
6.6% |
| Meningitis Aseptic |
5.5% |
| Anaphylactic Reaction |
4.0% |
| Headache |
3.7% |
| Sinusitis |
2.9% |
| Hypertension |
2.6% |
| Pain |
2.6% |
| Rash |
2.6% |
| Drug Exposure During Pregnancy |
2.2% |
| Infusion Related Reaction |
2.2% |
| Oxygen Saturation Decreased |
2.2% |
| Pulmonary Embolism |
2.2% |
| Throat Tightness |
2.2% |
| Deep Vein Thrombosis |
1.8% |
| Myocardial Infarction |
1.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
26.9% |
| Off Label Use |
16.8% |
| Immunodeficiency Common Variable |
9.2% |
| Product Used For Unknown Indication |
8.5% |
| Premedication |
8.2% |
| Polymyositis |
6.5% |
| Demyelinating Polyneuropathy |
3.9% |
| Primary Immunodeficiency Syndrome |
3.8% |
| Hypogammaglobulinaemia |
1.9% |
| Multifocal Motor Neuropathy |
1.8% |
| Stevens-johnson Syndrome |
1.8% |
| Toxic Epidermal Necrolysis |
1.8% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.5% |
| Epilepsy |
1.4% |
| Intentional Drug Misuse |
1.2% |
| Cutaneous Lupus Erythematosus |
1.0% |
| Myasthenia Gravis |
1.0% |
| Multiple Sclerosis |
1.0% |
| Sjogren's Syndrome |
0.9% |
| Hypertension |
0.9% |
|
| Hepatitis C |
23.7% |
| Death |
8.6% |
| Hiv Test Positive |
8.0% |
| Throat Tightness |
7.2% |
| Headache |
5.6% |
| Deep Vein Thrombosis |
4.8% |
| Asthenia |
4.4% |
| Pyrexia |
4.2% |
| Pain |
4.0% |
| Urinary Tract Inflammation |
4.0% |
| Varices Oesophageal |
4.0% |
| Vomiting |
3.6% |
| Drug Exposure During Pregnancy |
3.2% |
| Chills |
3.0% |
| Swelling |
2.4% |
| Tachycardia |
2.2% |
| Gastrointestinal Haemorrhage |
2.0% |
| Iritis |
2.0% |
| Rash |
1.8% |
| Drug Intolerance |
1.6% |
|
| Concomitant |
| Multiple Myeloma |
60.0% |
| Idiopathic Thrombocytopenic Purpura |
13.3% |
| Polymyositis |
13.3% |
| Drug Use For Unknown Indication |
6.7% |
| Immunodeficiency Common Variable |
6.7% |
|
| Blood Creatine Phosphokinase Increased |
14.3% |
| Haemolysis |
14.3% |
| Parvovirus Infection |
14.3% |
| Polymyositis |
14.3% |
| Pyrexia |
14.3% |
| Thrombocytopenia |
14.3% |
| Varices Oesophageal |
14.3% |
|
